Lanadelumab shortage status
1 active shortage notice across 1 country.
Last updated 30 Oct 2026 · sourced from official medicines regulators
- Generic name (INN)
- Lanadelumab
- Brand names
- Takhzyro
- Class
- Auto-created by Agenzia Italiana del Farmaco — Carenze scraper
Where Lanadelumab is in shortage
Why Lanadelumab is in shortage
- causes not stated by the regulator
Recent shortage history
- Italy: resolved 15 Sept 2022 (began 15 Sept 2022)
Frequently asked questions
Is Lanadelumab currently in shortage?
Yes. As of the latest regulator updates, Lanadelumab has 1 active shortage notice across 1 country (Colombia). Status is refreshed daily from official regulatory sources.
Why is Lanadelumab in shortage?
Regulators attribute the current Lanadelumab shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Lanadelumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Lanadelumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.